Xolair Injection - Uses and Administration
Xolair Injection FAQ
What is Xolair used for?
Xolair is a brand-name subcutaneous injection that’s prescribed for asthma, hives, and nasal polyps. Xolair is a biologic that contains the active drug omalizumab. moderate to severe asthma in certain people ages 6 years and older hives with an unknown cause in certain people ages 12 years and older You’ll find key information about Xolair below.
What is Xolair ® omalizumab?
Xolair® is a brand of omalizumab. This medication treats allergic asthma, chronic hives and nasal polyps. A healthcare provider will usually give you this injection in a hospital or clinic setting. They can teach you how to administer this medication at home. What is this medication? OMALIZUMAB (oh mah lye ZOO mab) prevents the symptoms of asthma.
How is Xolair given?
Xolair is given as an injection under the skin (subcutaneous injection). When you first start your treatment, the injection will be given to you by your healthcare provider. You will be watched closely for a short time after receiving the injection to make sure you do not have an allergic reaction to the medication.
Can I inject Xolair outside the doctor's office?
For uncontrolled moderate to severe allergic asthma patients 6 years and older. You and your doctor may determine that self-injection is right for you. This means that you or your caregiver can inject XOLAIR outside of the doctor's office–at home or while traveling–after initial training has been completed with your healthcare provider.
Does Xolair contain omalizumab?
Xolair contains the active substance omalizumab. Omalizumab is a man-made protein that is similar to natural proteins produced by the body. It belongs to a class of medicines called monoclonal antibodies. Xolair is used for the treatment of: Allergic asthma
Can Xolair be used as a self-injection?
XOLAIR self-injection is available for appropriate patients in all approved indications. Initiate XOLAIR only in a healthcare setting by healthcare providers prepared to manage anaphylaxis that can be life-threatening. For more information on anaphylaxis, read Boxed WARNING
How is Xolair dose determined?
The patient's pretreatment serum total immunoglobulin E (IgE) level (IU/mL) and body weight (lb or kg) are used to determined doses (mg) and dosing frequency. 4 For adult patients with both asthma and nasal polyps, dosing determination should be based on the primary diagnosis for which XOLAIR is being prescribed.
Xolair Injection References
If you want to know more about Xolair Injection, consider exploring links below:
What Is Xolair Injection
- https://www.drugs.com/xolair.html
- https://www.medicalnewstoday.com/articles/326828
- https://patient-info.co.uk/xolair-69945/patient-leaflet
- https://bnf.nice.org.uk/drugs/omalizumab/
- https://www.xolair.com/allergic-asthma/injections/self-injection.html
- https://my.clevelandclinic.org/health/drugs/19805-omalizumab-injection
- https://en.wikipedia.org/wiki/Omalizumab
- https://www.healthline.com/health/drugs/xolair
Xolair Injection Information
- https://www.royaldevon.nhs.uk/media/c0wf4don/patient-information-leaflet-omalizumab-xolair-rde-20-207-001.pdf
- https://www.xolairhcp.com/allergic-asthma/dosing-and-administration/administration.html
- https://www.medicines.org.uk/emc/files/pil.5327.pdf?filename=PIL.5327.pdf
- https://www.ema.europa.eu/en/medicines/human/EPAR/xolair
Explore Related Topics
Challenges in Adopting IoT Solutions for Asthma in Low-Income Areas
Addressing the challenges and barriers to adopting IoT solutions for asthma management in economically disadvantaged areas.
Can Pets Truly Aggravate Asthma Symptoms?
Discussing the impact of pet dander on asthma conditions and strategies for living harmoniously with pets for asthma sufferers.